FURQAN CHOUDHARY

Mr. FURQAN CHOUDHARY


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2025 in Journal of Nanotheranostics
Verified
Journal Article
Open access
PDF file
FCFURQAN CHOUDHARY
FURQAN CHOUDHARY
Ubaid Mushtaq NaikooUbaid Mushtaq Naikoo
Ubaid Mushtaq Naikoo
ARAmber Rizwan
Amber Rizwan
JKJasmeet Kaur
Jasmeet Kaur
MAMalik Zainul Abdin
Malik Zainul Abdin
HFHumaira Farooqi
Humaira Farooqi
Lung cancer remains one of the main causes of cancer-related death globally and a significant global health concern. There is an urgent need for safer and more effective therapeutic alternatives despite notable progress in therapy; issues such as drug resistance, side effects, metastasis, and recurrence still affect patient outcome and quality of life. The aim of this review is to examine recent developments in the application of herbal-drug-loaded nanoparticles as a new strategy for treating lung cancer. A thorough examination of different drug delivery systems based on nanoparticles is provided, highlighting their function in improving the solubility, bioavailability, and targeted delivery of herbal compounds. In addition, the review evaluates the biomarkers used for targeted therapy and examines how new personalised treatment approaches like wearable electronic patches, robotics-assisted interventions, smartphone-enabled therapies, AI-driven diagnostics, and lung-on-a-chip technologies can be integrated to improve the accuracy and effectiveness of lung cancer treatment. In conclusion, the combination of personalised medicine and nanotechnology may lead to revolutionary changes in lung cancer treatment in the future.

23 September 2024 in Sensors
Verified
Journal Article
Open access
PDF file
MHMohd Rahil Hasan
Mohd Rahil Hasan
CBChandra Bartholomeusz
Chandra Bartholomeusz
SSShifa Shaikh
Shifa Shaikh
FCFURQAN CHOUDHARY
FURQAN CHOUDHARY
ANAnam Nizam
Anam Nizam
JNJagriti Narang
Jagriti Narang
Breast cancer stands as the most prevalent form of cancer amongst females, constituting more than one-third of all cancer cases affecting women. It causes aberrant cell development, which can assault or spread to other sections of the body, perhaps leading to the patient’s death. Based on research findings, timely detection can diminish the likelihood of mortality and enhance the quality of healthcare provided for the illness. However, current technologies can only identify cancer at an advanced stage. Consequently, there is a substantial demand for rapid and productive approaches to detecting breast cancer. Researchers are actively pursuing precise and timely methods for the diagnosis of breast cancer, aiming to achieve enhanced accuracy and early detection. Biosensor technology can allow for the speedy and accurate diagnosis of cancer-related cells, as well as a more sensitive and specialized technique for generating them. Additionally, numerous treatments for breast cancer are depicted such as herbal therapy, nanomaterial-based drug delivery, miRNA targeting, CRISPR technology, immunotherapy, and precision medicine. Early detection and efficient therapy are necessary to manage such a severe illness properly.